Taribavirin Phase 2 Dose Finding Study for the Treatment of Hepatitis C Virus (HCV)

NCT00446134 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

278

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Hepatitis C

Interventions

DRUG: Taribavirin
DRUG: Taribavirin
DRUG: Taribavirin
DRUG: Ribavirin

Sponsor

Bausch Health Americas, Inc.